Idiopathic pulmonary fibrosis and gastroesophageal reflux disease: A population-based, case-control study. (March 2021)

• Record Type: Journal Article
• Authors: Baqir, Misbah; Vasirreddy, Amit; Vu, Ann N.; Moua, Teng; Chamberlain, Alanna M.; Frank, Ryan D.; Ryu, Jay H.
• Is Part Of: Respiratory medicine. Volume 178(2021)
• Publication Date: 2021-03
• Subjects: Gastroesophageal reflux -- Idiopathic pulmonary fibrosis -- Interstitial lung disease; AAT antacid therapy -- ATS/ERS American Thoracic Society/European Respiratory Society -- BMI body mass index -- CT computed tomographic -- DLCO diffusion capacity of the lungs for carbon monoxide -- FVC forced vital capacity -- GERD gastroesophageal reflux disease -- ICD 9/10 International Classification of Diseases Ninth Revision and Tenth Revision -- ILD interstitial lung disease -- IPF idiopathic pulmonary fibrosis -- OR odds ratio -- REP Rochester Epidemiology Project -- RVSP right ventricle systolic pressure -- UIP usual interstitial pneumonia; Chest -- Diseases -- Periodicals; Chest -- Diseases -- Great Britain -- Periodicals; Respiratory organs -- Diseases -- Periodicals; Respiratory Tract Diseases -- Periodicals; Appareil respiratoire -- Maladies -- Périodiques; Thorax -- Maladies -- Périodiques; Appareil respiratoire -- Maladies -- Traitement -- Périodiques; Electronic journals; 616.2
• DOI: 10.1016/j.rmed.2021.106309
• Languages: English
• ISSNs: 0954-6111

Abstract

Abstract: Background: It is unknown whether gastroesophageal reflux disease (GERD) is a risk factor or consequence of idiopathic pulmonary fibrosis (IPF). This study aimed to determine whether patients with IPF were more likely to have GERD compared with age- and sex-matched controls who either had 1) interstitial lung disease (ILD) other than IPF or 2) no diagnosed lung disease (population control). Methods: We used the medical records-linkage system of the Rochester Epidemiology Project (REP) to identify patients with IPF who resided in Olmsted County, Minnesota, from January 1, 1997, through June 30, 2017. IPF cases were each matched with patients from 2 control groups (non-IPF ILD controls and population controls). We used conditional logistic regression to model associations between GERD diagnosis and IPF case status. P values were adjusted for multiple comparisons by using the Bonferroni adjustment ( P values < .025 were considered statistically significant). Results: One hundred thirteen IPF cases were identified and matched to 226 population controls and 226 controls with non-IPF ILD. After multivariable adjustment, the odds of having GERD were 1.78 times higher (95% CI, 1.09–2.91; P = .02) in IPF cases compared with population controls. After multivariable adjustment, the odds of having GERD were 0.46 times lower (95% CI, 0.23–0.94; P = .03) in IPF cases compared with non-IPF ILD controls. Conclusion: GERD may be an important contributor to the development of lung fibrosis. Thus, it should be investigated and addressed adequately when detected in patients with IPF and patients with non-IPF ILD. Highlights: IPF patients had almost double the risk of having GERD compared with patients with no lung disease. The odds of GERD before a diagnosis of interstitial lung disease appeared greater in patients with non-IPF ILD than IPF. GERD may be an important contributor to the development of lung fibrosis.